1
|
Spoorthi Shetty S, Halagali P, Johnson AP, Spandana KMA, Gangadharappa HV. Oral insulin delivery: Barriers, strategies, and formulation approaches: A comprehensive review. Int J Biol Macromol 2023:125114. [PMID: 37263330 DOI: 10.1016/j.ijbiomac.2023.125114] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 05/23/2023] [Accepted: 05/24/2023] [Indexed: 06/03/2023]
Abstract
Diabetes Mellitus is characterized by a hyperglycemic condition which can either be caused by the destruction of the beta cells or by the resistance developed against insulin in the cells. Insulin is a peptide hormone that regulates the metabolism of carbohydrates, proteins, and fats. Type 1 Diabetes Mellitus needs the use of Insulin for efficient management. However invasive methods of administration may lead to reduced adherence by the patients. Hence there is a need for a non-invasive method of administration. Oral Insulin has several merits over the conventional method including patient compliance, and reduced cost, and it also mimics endogenous insulin and hence reaches the liver by the portal vein at a higher concentration and thereby showing improved efficiency. However oral Insulin must pass through several barriers in the gastrointestinal tract. Some strategies that could be utilized to bypass these barriers include the use of permeation enhancers, absorption enhancers, use of suitable polymers, use of suitable carriers, and other agents. Several formulation types have been explored for the oral delivery of Insulin like hydrogels, capsules, tablets, and patches which have been described briefly by the article. A lot of attempts have been made for developing oral insulin delivery however none of them have been commercialized due to numerous shortcomings. Currently, there are several formulations from the companies that are still in the clinical phase, the success or failure of some is yet to be seen in the future.
Collapse
Affiliation(s)
- S Spoorthi Shetty
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India
| | - Praveen Halagali
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India
| | - Asha P Johnson
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India
| | - K M Asha Spandana
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India
| | - H V Gangadharappa
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.
| |
Collapse
|
2
|
Masloh S, Culot M, Gosselet F, Chevrel A, Scapozza L, Zeisser Labouebe M. Challenges and Opportunities in the Oral Delivery of Recombinant Biologics. Pharmaceutics 2023; 15:pharmaceutics15051415. [PMID: 37242657 DOI: 10.3390/pharmaceutics15051415] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 04/22/2023] [Accepted: 04/24/2023] [Indexed: 05/28/2023] Open
Abstract
Recombinant biological molecules are at the cutting-edge of biomedical research thanks to the significant progress made in biotechnology and a better understanding of subcellular processes implicated in several diseases. Given their ability to induce a potent response, these molecules are becoming the drugs of choice for multiple pathologies. However, unlike conventional drugs which are mostly ingested, the majority of biologics are currently administered parenterally. Therefore, to improve their limited bioavailability when delivered orally, the scientific community has devoted tremendous efforts to develop accurate cell- and tissue-based models that allow for the determination of their capacity to cross the intestinal mucosa. Furthermore, several promising approaches have been imagined to enhance the intestinal permeability and stability of recombinant biological molecules. This review summarizes the main physiological barriers to the oral delivery of biologics. Several preclinical in vitro and ex vivo models currently used to assess permeability are also presented. Finally, the multiple strategies explored to address the challenges of administering biotherapeutics orally are described.
Collapse
Affiliation(s)
- Solene Masloh
- Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Faculté des sciences Jean Perrin, University of Artois, UR 2465, Rue Jean Souvraz, 62300 Lens, France
- Affilogic, 24 Rue de la Rainière, 44300 Nantes, France
- School of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel Servet, 1201 Geneva, Switzerland
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1201 Geneva, Switzerland
| | - Maxime Culot
- Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Faculté des sciences Jean Perrin, University of Artois, UR 2465, Rue Jean Souvraz, 62300 Lens, France
| | - Fabien Gosselet
- Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Faculté des sciences Jean Perrin, University of Artois, UR 2465, Rue Jean Souvraz, 62300 Lens, France
| | - Anne Chevrel
- Affilogic, 24 Rue de la Rainière, 44300 Nantes, France
| | - Leonardo Scapozza
- School of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel Servet, 1201 Geneva, Switzerland
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1201 Geneva, Switzerland
| | - Magali Zeisser Labouebe
- School of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel Servet, 1201 Geneva, Switzerland
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1201 Geneva, Switzerland
| |
Collapse
|
3
|
Kommineni N, Sainaga Jyothi VGS, Butreddy A, Raju S, Shapira T, Khan W, Angsantikul P, Domb AJ. SNAC for Enhanced Oral Bioavailability: An Updated Review. Pharm Res 2023; 40:633-650. [PMID: 36539668 DOI: 10.1007/s11095-022-03459-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2022] [Accepted: 12/05/2022] [Indexed: 12/24/2022]
Abstract
The delivery of proteins and peptides via an oral route poses numerous challenges to improve the oral bioavailability and patient compliance. To overcome these challenges, as well as to improve the permeation of proteins and peptides via intestinal mucosa, several chemicals have been studied such as surfactants, fatty acids, bile salts, pH modifiers, and chelating agents, amongst these medium chain fatty acid like C10 (sodium caprate) and Sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) and its derivatives that have been well studied from a clinical perspective. This current review enumerates the challenges involved in protein and peptide delivery via the oral route, i.e., non-invasive routes of protein and peptide administration. This review also covers the chemistry behind SNAC and toxicity as well as mechanisms to enhance the oral delivery of clinically proven molecules like simaglutide and other small molecules under clinical development, as well as other permeation enhancers for efficient delivery of proteins and peptides.
Collapse
Affiliation(s)
- Nagavendra Kommineni
- Center for Biomedical Research, Population Council, New York, NY, 10065, USA.
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India.
| | - Vaskuri G S Sainaga Jyothi
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India
| | - Arun Butreddy
- Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, Oxford, MS, 38677, USA
| | - Saka Raju
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India
| | - Tovi Shapira
- School of Pharmacy and Faculty of Medicine, The Hebrew University of Jerusalem, Hadassah Medical Center, Ein Kerem Campus, 91120, Jerusalem, Israel
| | - Wahid Khan
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India
- Natco Research Centre, NATCO Pharma Limited, Hyderabad, 500018, India
| | - Pavimol Angsantikul
- Center for Biomedical Research, Population Council, New York, NY, 10065, USA
| | - Abraham J Domb
- School of Pharmacy and Faculty of Medicine, The Hebrew University of Jerusalem, Hadassah Medical Center, Ein Kerem Campus, 91120, Jerusalem, Israel.
| |
Collapse
|
4
|
Chang HHR, Chen K, Lugtu-Pe JA, AL-Mousawi N, Zhang X, Bar-Shalom D, Kane A, Wu XY. Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery. Pharmaceutics 2023; 15:pharmaceutics15020547. [PMID: 36839869 PMCID: PMC9964771 DOI: 10.3390/pharmaceutics15020547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 01/17/2023] [Accepted: 01/26/2023] [Indexed: 02/10/2023] Open
Abstract
Bioavailability of weakly basic drugs may be disrupted by dramatic pH changes or unexpected pH alterations in the gastrointestinal tract. Conventional organic acids or enteric coating polymers cannot address this problem adequately because they leach out or dissolve prematurely, especially during controlled release applications. Thus, a non-leachable, multifunctional terpolymer nanoparticle (TPN) made of cross-linked poly(methacrylic acid) (PMAA)-polysorbate 80-grafted-starch (PMAA-PS 80-g-St) was proposed to provide pH transition-independent release of a weakly basic drug, verapamil HCl (VER), by a rationally designed bilayer-coated controlled release bead formulation. The pH-responsive PMAA and cross-linker content in the TPN was first optimized to achieve the largest possible increase in medium uptake alongside the smallest decrease in drug release rate at pH 6.8, relative to pH 1.2. Such TPNs maintained an acidic microenvironmental pH (pHm) when loaded in ethylcellulose (EC) films, as measured using pH-indicating dyes. Further studies of formulations revealed that with the 1:2 VER:TPN ratio and 19% coating weight gain, bilayer-coated beads maintained a constant release rate over the pH transition and exhibited extended release up to 18 h. These results demonstrated that the multifunctional TPN as a pHm modifier and pH-dependent pore former could overcome the severe pH-dependent solubility of weakly basic drugs.
Collapse
Affiliation(s)
- Hao Han R. Chang
- Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
| | - Kuan Chen
- Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
| | - Jamie Anne Lugtu-Pe
- Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
| | - Nour AL-Mousawi
- Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
- Department of Pharmacy, University of Copenhagen, 2100 Copenhagen Ø, Denmark
| | - Xuning Zhang
- Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
| | - Daniel Bar-Shalom
- Department of Pharmacy, University of Copenhagen, 2100 Copenhagen Ø, Denmark
| | - Anil Kane
- Patheon by Thermo Fisher Scientific, Toronto Region Operations (TRO), Mississauga, ON L5N 3X4, Canada
| | - Xiao Yu Wu
- Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
- Correspondence: ; Tel.: +1-(416)-978-5272
| |
Collapse
|
5
|
Wen H, Yang Y, Geng X. Market entry system considering the biosafety of nanomedical devices in China. WIRES NANOMEDICINE AND NANOBIOTECHNOLOGY 2022; 14:e1821. [DOI: 10.1002/wnan.1821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/31/2021] [Revised: 03/18/2022] [Accepted: 04/12/2022] [Indexed: 11/24/2022]
Affiliation(s)
- Hairuo Wen
- National Center for Safety Evaluation of Drugs National Institutes for Food and Drug Control Beijing People's Republic of China
| | - Ying Yang
- National Center for Safety Evaluation of Drugs National Institutes for Food and Drug Control Beijing People's Republic of China
| | - Xingchao Geng
- National Center for Safety Evaluation of Drugs National Institutes for Food and Drug Control Beijing People's Republic of China
| |
Collapse
|
6
|
Islam MS, Renner F, Foster K, Oderinde MS, Stefanski K, Mitra S. Enhanced aqueous dissolution of hydrophobic apixaban via direct incorporation of hydrophilic nanographene oxide. Colloids Surf B Biointerfaces 2022; 216:112512. [PMID: 35533561 DOI: 10.1016/j.colsurfb.2022.112512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 04/13/2022] [Accepted: 04/19/2022] [Indexed: 11/19/2022]
Abstract
In this study, we have directly incorporated nanographene oxide (nGO) into a hydrophobic drug for enhanced dissolution performance through an antisolvent technique. Apixaban (APX) drug composites were synthesized with nGO incorporation ranging from 0.8% to 2.0% concentration. It was observed that the nGO was successfully embedded without any changes to the original drug crystal structure or physical properties. Dissolution of the drug composites was evaluated using US Pharmacopeia Paddle Method (USP 42). The time needed to reach a 50% release (T50) reduced from 106 min to 24 min with the integration of 1.96% nGO in APX and the T80 also dropped accordingly. Alternatively, dissolution rate showed promising performance with increase in nGO concentration. Initial dissolution rate increased dramatically from 74 µg/min to 540 µg/min. Further, work done in intestinal media revealed T50 went from not dissolving to 79.0 min. Decreased lipophilicity or logP value and increased aqueous solubility are both accredited to hydrophilic nGO water dispersion, producing a hydrophilic channel into the drug crystal surfaces through intermolecular interaction. Additionally, physical, and chemical characterizations confirm that hydrophobic apixaban was successfully transformed into a hydrophilic composite, showing potential for this technology to improve dissolution rate of a model hydrophobic compound.
Collapse
Affiliation(s)
- Mohammad Saiful Islam
- Department of Chemistry and Environmental science, New Jersey Institute of Technology, Newark, NJ, 07102, USA
| | - Faradae Renner
- Department of Chemistry and Environmental science, New Jersey Institute of Technology, Newark, NJ, 07102, USA; Bristol Myers Squibb Research and Early Development, Princeton, NJ 08543, USA
| | - Kimberly Foster
- Bristol Myers Squibb Research and Early Development, Princeton, NJ 08543, USA
| | - Martins S Oderinde
- Bristol Myers Squibb Research and Early Development, Princeton, NJ 08543, USA
| | - Kevin Stefanski
- Bristol Myers Squibb Research and Early Development, Princeton, NJ 08543, USA
| | - Somenath Mitra
- Department of Chemistry and Environmental science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
| |
Collapse
|
7
|
Sohail Arshad M, Zafar S, Yousef B, Alyassin Y, Ali R, AlAsiri A, Chang MW, Ahmad Z, Ali Elkordy A, Faheem A, Pitt K. A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing. Adv Drug Deliv Rev 2021; 178:113840. [PMID: 34147533 DOI: 10.1016/j.addr.2021.113840] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2021] [Revised: 06/08/2021] [Accepted: 06/14/2021] [Indexed: 12/20/2022]
Abstract
Tablets are the most widely utilized solid oral dosage forms because of the advantages of self-administration, stability, ease of handling, transportation, and good patient compliance. Over time, extensive advances have been made in tableting technology. This review aims to provide an insight about the advances in tablet excipients, manufacturing, analytical techniques and deployment of Quality by Design (QbD). Various excipients offering novel functionalities such as solubility enhancement, super-disintegration, taste masking and drug release modifications have been developed. Furthermore, co-processed multifunctional ready-to-use excipients, particularly for tablet dosage forms, have benefitted manufacturing with shorter processing times. Advances in granulation methods, including moist, thermal adhesion, steam, melt, freeze, foam, reverse wet and pneumatic dry granulation, have been proposed to improve product and process performance. Furthermore, methods for particle engineering including hot melt extrusion, extrusion-spheronization, injection molding, spray drying / congealing, co-precipitation and nanotechnology-based approaches have been employed to produce robust tablet formulations. A wide range of tableting technologies including rapidly disintegrating, matrix, tablet-in-tablet, tablet-in-capsule, multilayer tablets and multiparticulate systems have been developed to achieve customized formulation performance. In addition to conventional invasive characterization methods, novel techniques based on laser, tomography, fluorescence, spectroscopy and acoustic approaches have been developed to assess the physical-mechanical attributes of tablet formulations in a non- or minimally invasive manner. Conventional UV-Visible spectroscopy method has been improved (e.g. fiber-optic probes and UV imaging-based approaches) to efficiently record the dissolution profile of tablet formulations. Numerous modifications in tableting presses have also been made to aid machine product changeover, cleaning, and enhance efficiency and productivity. Various process analytical technologies have been employed to track the formulation properties and critical process parameters. These advances will contribute to a strategy for robust tablet dosage forms with excellent performance attributes.
Collapse
Affiliation(s)
| | - Saman Zafar
- Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
| | - Bushra Yousef
- Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom
| | - Yasmine Alyassin
- Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom
| | - Radeyah Ali
- Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom
| | - Ali AlAsiri
- Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom; Pharmacy College, Pharmaceutics Department, Najran University, Najran, Saudi Arabia
| | - Ming-Wei Chang
- Nanotechnology and Integrated Bioengineering Centre, University of Ulster, Jordanstown Campus, Newtownabbey BT37 0QB, Northern Ireland, United Kingdom
| | - Zeeshan Ahmad
- Leicester School of Pharmacy, De Montfort University, Leicester, United Kingdom
| | - Amal Ali Elkordy
- School of Pharmacy and Pharmaceutical Sciences, Faculty of Health Sciences and Wellbeing,University of Sunderland, Sunderland, United Kingdom
| | - Ahmed Faheem
- School of Pharmacy and Pharmaceutical Sciences, Faculty of Health Sciences and Wellbeing,University of Sunderland, Sunderland, United Kingdom; Faculty of Pharmacy, University of Tanta, Tanta, Egypt
| | - Kendal Pitt
- Manufacturing, Science & Technology, Pharma Supply Chain, GlaxoSmithKline, Ware, United Kingdom.
| |
Collapse
|
8
|
Pooresmaeil M, Javanbakht S, Namazi H, Shaabani A. Application or function of citric acid in drug delivery platforms. Med Res Rev 2021; 42:800-849. [PMID: 34693555 DOI: 10.1002/med.21864] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Revised: 08/02/2021] [Accepted: 10/12/2021] [Indexed: 12/11/2022]
Abstract
Nontoxic materials with natural origin are promising materials in the designing and preparation of the new drug delivery systems (DDSs). Today's, citric acid (CA) has attracted a great deal of attention because of its special features; green nature, biocompatibility, low price, biodegradability, and commercially available property. So, CA has been employed in the preparation of the various platforms to induce a suitable property on their structure. Recently, several research groups investigated the CA-based platforms in different forms like tablets, dendrimers, hyperbranched polymers, (co)polymer, hydrogels, and nanoparticles as efficient DDSs. By considering an increasing amount of published articles in this field, for the first time, in this review, an overview of the published works regarding CA applications in the design of various DDSs is presented with a detailed and insightful discussion.
Collapse
Affiliation(s)
- Malihe Pooresmaeil
- Polymer Research Laboratory, Department of Organic and Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran
| | | | - Hassan Namazi
- Polymer Research Laboratory, Department of Organic and Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.,Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Science, Tabriz, Iran
| | - Ahmad Shaabani
- Faculty of Chemistry, Shahid Beheshti University, Tehran, Iran
| |
Collapse
|
9
|
Mašková E, Kubová K, Raimi-Abraham BT, Vllasaliu D, Vohlídalová E, Turánek J, Mašek J. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery. J Control Release 2020; 324:695-727. [PMID: 32479845 DOI: 10.1016/j.jconrel.2020.05.045] [Citation(s) in RCA: 88] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 05/27/2020] [Accepted: 05/27/2020] [Indexed: 02/07/2023]
Abstract
Hydroxypropylmethylcellulose (HPMC), also known as Hypromellose, is a traditional pharmaceutical excipient widely exploited in oral sustained drug release matrix systems. The choice of numerous viscosity grades and molecular weights available from different manufacturers provides a great variability in its physical-chemical properties and is a basis for its broad successful application in pharmaceutical research, development, and manufacturing. The excellent mucoadhesive properties of HPMC predetermine its use in oromucosal delivery systems including mucoadhesive tablets and films. HPMC also possesses desirable properties for formulating amorphous solid dispersions increasing the oral bioavailability of poorly soluble drugs. Printability and electrospinnability of HPMC are promising features for its application in 3D printed drug products and nanofiber-based drug delivery systems. Nanoparticle-based formulations are extensively explored as antigen and protein carriers for the formulation of oral vaccines, and oral delivery of biologicals including insulin, respectively. HPMC, being a traditional pharmaceutical excipient, has an irreplaceable role in the development of new pharmaceutical technologies, and new drug products leading to continuous manufacturing processes, and personalized medicine. This review firstly provides information on the physical-chemical properties of HPMC and a comprehensive overview of its application in traditional oral drug formulations. Secondly, this review focuses on the application of HPMC in modern pharmaceutical technologies including spray drying, hot-melt extrusion, 3D printing, nanoprecipitation and electrospinning leading to the formulation of printlets, nanoparticle-, microparticle-, and nanofiber-based delivery systems for oral and oromucosal application. Hypromellose is an excellent excipient for formulation of classical dosage forms and advanced drug delivery systems. New methods of hypromellose processing include spray draying, hot-melt extrusion, 3D printing, and electrospinning.
Collapse
Affiliation(s)
- Eliška Mašková
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic
| | - Kateřina Kubová
- Faculty of Pharmacy, Masaryk University, Brno 625 00, Czech Republic
| | - Bahijja T Raimi-Abraham
- School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Driton Vllasaliu
- School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Eva Vohlídalová
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic
| | - Jaroslav Turánek
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic.
| | - Josef Mašek
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic.
| |
Collapse
|
10
|
Elagamy HI, Essa EA, Nouh A, El Maghraby GM. Development and evaluation of rapidly dissolving buccal films of naftopidil:in vitroandin vivoevaluation. Drug Dev Ind Pharm 2019; 45:1695-1706. [DOI: 10.1080/03639045.2019.1656734] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Heba I. Elagamy
- Department of Pharmaceutics, Pharmacy College, Delta University for Science and Technology, Egypt
| | - Ebtessam A. Essa
- Department of Pharmaceutical Technology, Pharmacy College, Tanta University, Egypt
| | - Ahmed Nouh
- Department of Pharmaceutics, Pharmacy College, Delta University for Science and Technology, Egypt
| | - Gamal M. El Maghraby
- Department of Pharmaceutical Technology, Pharmacy College, Tanta University, Egypt
| |
Collapse
|
11
|
Clitherow KH, Murdoch C, Spain SG, Handler AM, Colley HE, Stie MB, Mørck Nielsen H, Janfelt C, Hatton PV, Jacobsen J. Mucoadhesive Electrospun Patch Delivery of Lidocaine to the Oral Mucosa and Investigation of Spatial Distribution in a Tissue Using MALDI-Mass Spectrometry Imaging. Mol Pharm 2019; 16:3948-3956. [PMID: 31361498 PMCID: PMC7007276 DOI: 10.1021/acs.molpharmaceut.9b00535] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
![]()
Many
oral mucosal conditions cause considerable and prolonged pain
that to date has been difficult to alleviate via topical delivery,
and the use of injection causes many patients dental anxiety and needle-prick
pain. Therefore, developing a noninjectable drug delivery system as
an alternative administration procedure may vastly improve the health
and wellbeing of these patients. Recent advances in the development
of mucoadhesive electrospun patches for the direct delivery of therapeutics
to the oral mucosa offer a potential solution, but as yet, the release
of local anesthetics from this system and their uptake by oral tissue
have not been demonstrated. Here, we demonstrate the fabrication of
lidocaine-loaded electrospun fiber patches, drug release, and subsequent
uptake and permeation through the porcine buccal mucosa. Lidocaine
HCl and lidocaine base were incorporated into the electrospun patches
to evaluate the difference in drug permeation for the two drug compositions.
Lidocaine released from the lidocaine HCl-containing electrospun patches
was significantly quicker than from the lidocaine base patches, with
double the amount of drug released from the lidocaine HCl patches
in the first 15 min (0.16 ± 0.04 mg) compared to that from the
lidocaine base patches (0.07 ± 0.01 mg). The permeation of lidocaine
from the lidocaine HCl electrospun patches through ex vivo porcine
buccal mucosa was also detected in 15 min, whereas permeation of lidocaine
from the lidocaine base patch was not detected. Matrix-assisted laser
desorption ionization-mass spectrometry imaging was used to investigate
localization of lidocaine within the oral tissue. Lidocaine in the
solution as well as from the mucoadhesive patch penetrated into the
buccal mucosal tissue in a time-dependent manner and was detectable
in the lamina propria after only 15 min. Moreover, the lidocaine released
from lidocaine HCl electrospun patches retained biological activity,
inhibiting veratridine-mediated opening of voltage-gated sodium channels
in SH-SY5Y neuroblastoma cells. These data suggest that a mucoadhesive
electrospun patch may be used as a vehicle for rapid uptake and sustained
anesthetic drug delivery to treat or prevent oral pain.
Collapse
Affiliation(s)
- Katharina H Clitherow
- School of Clinical Dentistry , University of Sheffield , 19 Claremont Crescent , Sheffield S10 2TA , U.K
| | - Craig Murdoch
- School of Clinical Dentistry , University of Sheffield , 19 Claremont Crescent , Sheffield S10 2TA , U.K
| | - Sebastian Guy Spain
- Department of Chemistry , University of Sheffield , Brook Hill , Sheffield S3 7HF , U.K
| | - Anna Mette Handler
- Department of Pharmacy , University of Copenhagen , 2 Universitetsparken , Copenhagen DK-2100 , Denmark
| | - Helen E Colley
- School of Clinical Dentistry , University of Sheffield , 19 Claremont Crescent , Sheffield S10 2TA , U.K
| | - Mai Bay Stie
- Department of Pharmacy , University of Copenhagen , 2 Universitetsparken , Copenhagen DK-2100 , Denmark
| | - Hanne Mørck Nielsen
- Department of Pharmacy , University of Copenhagen , 2 Universitetsparken , Copenhagen DK-2100 , Denmark
| | - Christian Janfelt
- Department of Pharmacy , University of Copenhagen , 2 Universitetsparken , Copenhagen DK-2100 , Denmark
| | - Paul V Hatton
- School of Clinical Dentistry , University of Sheffield , 19 Claremont Crescent , Sheffield S10 2TA , U.K
| | - Jette Jacobsen
- Department of Pharmacy , University of Copenhagen , 2 Universitetsparken , Copenhagen DK-2100 , Denmark
| |
Collapse
|
12
|
Censi R, Gigliobianco MR, Casadidio C, Di Martino P. Hot Melt Extrusion: Highlighting Physicochemical Factors to Be Investigated While Designing and Optimizing a Hot Melt Extrusion Process. Pharmaceutics 2018; 10:E89. [PMID: 29997332 PMCID: PMC6160992 DOI: 10.3390/pharmaceutics10030089] [Citation(s) in RCA: 77] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 06/22/2018] [Accepted: 07/09/2018] [Indexed: 12/15/2022] Open
Abstract
Hot-melt extrusion (HME) is a well-accepted and extensively studied method for preparing numerous types of drug delivery systems and dosage forms. It offers several advantages: no solvents are required, it is easy to scale up and employ on the industrial level, and, in particular, it offers the possibility of improving drug bioavailability. HME involves the mixing of a drug with one or more excipients, in general polymers and even plasticizers, which can melt, often forming a solid dispersion of the drug in the polymer. The molten mass is extruded and cooled, giving rise to a solid material with designed properties. This process, which can be realized using different kinds of special equipment, may involve modifications in the drug physicochemical properties, such as chemical, thermal and mechanical characteristics thus affecting the drug physicochemical stability and bioavailability. During process optimization, the evaluation of the drug solid state and stability is thus of paramount importance to guarantee stable drug properties for the duration of the drug product shelf life. This manuscript reviews the most important physicochemical factors that should be investigated while designing and optimizing a hot melt extrusion process, and by extension, during the different pre-formulation, formulation and process, and post-formulation phases. It offers a comprehensive evaluation of the chemical and thermal stability of extrudates, the solid physical state of extrudates, possible drug-polymer interactions, the miscibility/solubility of the drug-polymer system, the rheological properties of extrudates, the physicomechanical properties of films produced by hot melt extrusion, and drug particle dissolution from extrudates. It draws upon the last ten years of research, extending inquiry as broadly as possible.
Collapse
Affiliation(s)
- Roberta Censi
- School of Pharmacy, University of Camerino, Via S. Agostino, 62032 Camerino, Italy.
| | | | - Cristina Casadidio
- School of Pharmacy, University of Camerino, Via S. Agostino, 62032 Camerino, Italy.
| | - Piera Di Martino
- School of Pharmacy, University of Camerino, Via S. Agostino, 62032 Camerino, Italy.
| |
Collapse
|
13
|
Mašková E, Kubová K, Vysloužil J, Pavloková S, Vetchý D. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis. AAPS PharmSciTech 2017; 18:1242-1253. [PMID: 27474035 DOI: 10.1208/s12249-016-0588-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2016] [Accepted: 07/04/2016] [Indexed: 11/30/2022] Open
Abstract
The solubility of weakly basic drugs in passage through gastrointestinal tract leads to their pH-dependent release from extended release formulations and to lower drug absorption and bioavailability. The aim of this study was to modulate the micro-environmental pH of hypromellose/montanglycol wax matrices and to observe its influence on the release of weakly basic drug verapamil hydrochloride (VH) with a pH-dependent solubility with respect to gel layer formation and its dynamics. For this study, malic and succinic acids differing in their solubility and pKa were selected as pH modifiers. The dissolution studies were performed by the method of changing pH. Within the same conditions, pH, thickness, and penetration force of the gel layer were measured as well. From the PCA sub-model, it is evident that a higher acid concentration ensured lower gel pH and conditions for higher drug solubility, thus creating larger gel layer with smaller rigidity, resulting in higher VH release during the dissolution test. Incorporation of stronger and more soluble malic acid (100 mg/tablet) created the most acidic and the thickest gel layer through which a total of 74% of VH was released. Despite having lower strength and solubility, matrices containing succinic acid (100 mg/tablet) released a comparable 71% of VH in a manner close to zero-order kinetics. The thinner and less rigid gel layers of the succinic acid matrices allowed an even slightly faster VH release at pH 6.8 than from matrices containing malic acid. Thus acid solubility is more parametrically significant than acid pKa for drug release at pH 6.8.
Collapse
|
14
|
Advances in hot-melt extrusion technology toward pharmaceutical objectives. JOURNAL OF PHARMACEUTICAL INVESTIGATION 2017. [DOI: 10.1007/s40005-017-0309-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Influence of HPMC K100LV and Compritol® HD5 ATO on Drug Release and Rheological Behavior of HPMC K4M Matrix Tablets. J Pharm Innov 2017. [DOI: 10.1007/s12247-016-9269-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Alshehri SM, Tiwari RV, Alsulays BB, Ashour EA, Alshetaili AS, Almutairy B, Park JB, Morott J, Sandhu B, Majumdar S, Repka MA. Investigation of the combined effect of MgO and PEG on the release profile of mefenamic acid prepared via hot-melt extrusion techniques. Pharm Dev Technol 2016; 22:740-753. [PMID: 26821841 DOI: 10.3109/10837450.2016.1138129] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
This study aimed to investigate the combined effect of magnesium oxide (MgO) as an alkalizer and polyethylene glycol (PEG) as a plasticizer and wetting agent in the presence of Kollidon® 12 PF and 17 PF polymer carriers on the release profile of mefenamic acid (MA), which was prepared via hot-melt extrusion technique. Various drug loads of MA and various ratios of the polymers, PEG 3350 and MgO were blended using a V-shell blender and extruded using a twin-screw extruder (16-mm Prism EuroLab, ThermoFisher Scientific, Carlsbad, CA) at different screw speeds and temperatures to prepare a solid dispersion system. Differential scanning calorimetry and X-ray diffraction data of the extruded material confirmed that the drug existed in the amorphous form, as evidenced by the absence of corresponding peaks. MgO and PEG altered the micro-environmental pH to be more alkaline (pH 9) and increased the hydrophilicity and dispersibility of the extrudates to enhance MA solubility and release, respectively. The in vitro release study demonstrated an immediate release for 2 h with more than 80% drug release within 45 min in matrices containing MgO and PEG in combination with polyvinylpyrrolidone when compared to the binary mixture, physical mixture and pure drug.
Collapse
Affiliation(s)
- Sultan M Alshehri
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA
| | - Roshan V Tiwari
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA
| | - Bader B Alsulays
- b Department of Pharmaceutics , College of Pharmacy, Prince Sattam Bin Abdulaziz University , Alkharj , Saudi Arabia
| | - Eman A Ashour
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA
| | - Abdullah S Alshetaili
- b Department of Pharmaceutics , College of Pharmacy, Prince Sattam Bin Abdulaziz University , Alkharj , Saudi Arabia
| | - Bjad Almutairy
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA
| | - Jun-Bom Park
- c College of Pharmacy, Sahm Yook University , Seoul , Korea
| | - Joseph Morott
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA
| | - Bhupinder Sandhu
- d Department of Chemistry , Kansas State University , Manhattan , KS , USA , and
| | - Soumyajit Majumdar
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA
| | - Michael A Repka
- a Department of Pharmaceutics and Drug Delivery , School of Pharmacy, The University of Mississippi, University , MS , USA.,e Pii Center for Pharmaceutical Technology, School of Pharmacy, The University of Mississippi, University , MS , USA
| |
Collapse
|
17
|
Patil H, Tiwari RV, Upadhye SB, Vladyka RS, Repka MA. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Int J Pharm 2015; 496:33-41. [DOI: 10.1016/j.ijpharm.2015.04.009] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2015] [Revised: 03/28/2015] [Accepted: 04/06/2015] [Indexed: 10/23/2022]
|
18
|
Patil HG, Tiwari RV, Repka MA, Singh KK. Formulation and development of orodispersible sustained release tablet of domperidone. Drug Dev Ind Pharm 2015; 42:906-15. [DOI: 10.3109/03639045.2015.1088864] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Hemlata G. Patil
- C.U. Shah College of Pharmacy, SNDT Women’s University, Mumbai, Maharashta, India,
| | - Roshan V. Tiwari
- Department of Pharmaceutics & Drug Delivery, University of Mississippi, University, MS, USA, and
| | - Michael A. Repka
- Department of Pharmaceutics & Drug Delivery, University of Mississippi, University, MS, USA, and
| | - Kamalinder K. Singh
- C.U. Shah College of Pharmacy, SNDT Women’s University, Mumbai, Maharashta, India,
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, UK
| |
Collapse
|
19
|
He W, Wu M, Huang S, Yin L. Matrix tablets for sustained release of repaglinide: Preparation, pharmacokinetics and hypoglycemic activity in beagle dogs. Int J Pharm 2015; 478:297-307. [DOI: 10.1016/j.ijpharm.2014.11.059] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2014] [Revised: 11/14/2014] [Accepted: 11/26/2014] [Indexed: 10/24/2022]
|